skip to Main Content

Foundations and Advocacy Groups

chm

Choroideremia Research Foundation (CRF)

Our 2016 partnership with the Chorolderemia Research Foundation is to develop a gene therapy product optimized for intravitreal administration to treat Choroideremia, a hereditary retinal degenerative disease. The Foundation brings clinical expertise, a network of doctors, trial investigators and patients together to inform product clinical and trial design and execution.

Cystic Fibrosis Foundation (CFF)

Our 2015 and 2017 grants from the Cystic Fibrosis Foundation are to support development of a gene therapy product optimized for aerosolized delivery to treat cystic fibrosis, a hereditary lung disease. The Foundation brings research and clinical expertise, a network of doctors, trial investigators and patients together to inform product design, R&D, clinical trial design and execution.

Foundation Fighting Blindness (FFB)

Our 2017 partnership with the Foundation Fighting Blindness is to develop gene therapy products optimized for intravitreal administration to treat inherited retinal diseases. The Foundation brings a wide range of strengths to our collaboration, including the following: clinical expertise, a network of physician-scientist leaders and key opinion leaders, trial investigators, patients.

Back To Top